That's a very good question.
That's the beauty of innovations, right? When we found the antiretroviral treatments and were able to make them available equitably to all people who needed them, we made a huge step forward in the fight against the disease. Where we are struggling is indeed in stopping new infections from happening. Obviously that means we will always have a large population of people who would need ARV treatment for life going forward, and this is not a good prospect.
The key challenges are discrimination, criminalization, gender inequity, poverty and vulnerability. These are all factors that drive new HIV infections, very clearly. This is why I was referring at the beginning to our investment in breaking down barriers to health and our focus on gender.